Credo Technology Group Holding Ltd. — Form 10-K Summary
Period: Fiscal year ended April 29, 2023 (52 weeks), compared with fiscal year ended April 30, 2022. This is an annual filing, not a standalone 2022 fourth-quarter report.
Business context
Credo develops high-speed connectivity products and SerDes intellectual-property solutions for data infrastructure, including hyperscale data centers, networking, and emerging AI/ML infrastructure. Its fabless product portfolio includes integrated circuits, active electrical cables (AECs), SerDes chiplets, and licensed IP. The company relies on third parties, including TSMC for all semiconductor wafer production.
Financial performance and liquidity
| Metric (USD millions, except per-share data) | FY2023 | FY2022 |
|---|---|---|
| Revenue | 184.2 | 106.5 |
| Gross profit / gross margin | 106.2 / 57.7% | 64.0 / 60.1% |
| Operating loss | (21.2) | (22.0) |
| Net loss | (16.5) | (22.2) |
| Diluted loss per share | (0.11) | (0.25) |
| Cash used in operating activities | (24.6) | (30.8) |
| Cash used in investing activities | (130.9) | (17.6) |
| Cash provided by financing activities | 4.9 | 204.2 |
- Revenue rose 73.0%. Product sales were $141.5 million, up 91.9%, and product engineering services were $10.8 million. IP license revenue was $29.4 million, up 26.3%.
- AEC shipments accounted for more than 90% of the increase in product sales, supported by a ramp at the company’s first hyperscale data-center customer. A $21.5 million IP license delivery to one customer was recognized in FY2023, versus $11.6 million from that customer in FY2022.
- Gross margin fell 2.4 percentage points, primarily because product sales, which carry lower margins than IP licensing, made up a larger share of revenue. Product-sales gross margin improved to 46.9% from 45.6%.
- Research and development expense increased 60.1% to $76.8 million; selling, general and administrative expense rose 38.2% to $48.2 million. Operating expenses declined as a share of revenue, but remained above gross profit.
- Cash and cash equivalents were $108.6 million at year-end, with $109.2 million of short-term investments; working capital was $297.2 million. Investing cash outflow included $159.2 million of certificate-of-deposit purchases, partly offset by $50.0 million of maturities, and $21.7 million of property and equipment purchases.
- Operating cash outflow reflected working-capital investment, including higher receivables and inventory. Inventory was $46.0 million, up from $27.3 million. The filing reports no interest-bearing borrowings; liabilities primarily include payables, accrued expenses, and operating leases.
- Total assets were $397.3 million and total liabilities were $49.7 million. The company reported an accumulated deficit of $107.0 million.
Material changes and outlook
- The largest customer reduced its forecast for certain products in February 2023, for reasons management understood to be unrelated to Credo’s performance. Management said the reduction affected FY2023 fourth-quarter revenue and would have a substantial negative impact on FY2024 revenue and results; it did not expect the customer’s market share to be affected.
- Product revenue increased from 77% to 83% of total revenue, while IP license and related engineering revenue declined from 23% to 17%. Management expects product sales to represent a growing share over time and anticipates long-term operating leverage as the business scales.
- The filing provides no numerical forward revenue or earnings guidance. Management believes existing cash, cash equivalents, and other working-capital resources will be sufficient for at least the next 12 months, while noting that future capital needs depend on growth, spending, and customer demand.
- Management identified demand for higher-speed data-center connectivity, including AI/ML infrastructure, as a growth opportunity. It cautioned that AI/ML and generative-AI markets are developing and that adoption, commercial viability, and regulation remain uncertain.
Risks, contingencies, and unusual items
- Customer concentration is substantial: the top 10 customers generated about 90% of FY2023 revenue; three customers represented 46%, 13%, and 12%. Customers generally lack long-term purchase commitments and may cancel, delay, or change orders.
- Revenue is exposed to semiconductor cycles, customer capital spending, pricing pressure, product transitions, forecast errors, inventory obsolescence, and lengthy design-win and qualification cycles. FY2023 included $5.7 million of excess and obsolete inventory write-downs, compared with $1.4 million in FY2022.
- Manufacturing is concentrated in third parties and Asia, including Taiwan. The filing highlights capacity, yield, supply-chain, natural-disaster, trade-control, and cross-strait geopolitical risks. Non-cancelable commitments included $40.6 million for manufacturing vendors and $12.0 million for technology licenses. A capacity-reservation arrangement included estimated purchase commitments of at least $35.5 million over FY2024–FY2028 and refundable deposits.
- Credo recognized $2.4 million of impairment charges in FY2023, primarily for property and equipment that did not reach production qualification. The filing also describes a remaining milestone in a $43.5 million IP licensing and development contract as constrained because delivery depended on customer actions.
- The company disclosed an export-control matter involving three evaluation boards supplied without required licenses in 2020. BIS closed the matter with a warning letter in September 2021; Credo says it enhanced training, systems, and controls.
- No litigation was pending as of the financial statements’ issuance date, and no loss-contingency accruals were recorded. Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting; management reported controls effective.
Important facts for investors to verify
- Customer-level concentration and the largest customer’s updated forecasts, order timing, and actual FY2024 purchases.
- Whether AEC growth and newer product programs convert design wins and qualifications into sustained volume shipments.
- Inventory aging, reserve adequacy, and cash conversion as receivables and inventory grow.
- Gross-margin progression as product revenue expands, including pricing, product mix, yields, and manufacturing costs.
- Execution and exposure under manufacturing-capacity reservations, purchase commitments, and the constrained IP-contract milestone.
- Reliance on TSMC and Asian manufacturing, and any developments in supply availability, export controls, or Taiwan-related geopolitical risk.